secwatch / observer
8-K filed August 21, 2023, 7:59 PM ET CIK 0001829966
regulatory confidence high sentiment negative materiality 0.85

EBET, Inc.: Nasdaq/NYSE listing notice — EBET faces Nasdaq delisting for equity deficiency; preferred conversion dilutes shares

EBET, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

EBET, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).

Exchange
nasdaq
Notice
delisting notice
Deficiency
minimum bid price
Rules
5550(a)(2), 5810(c)(3)(A)(iii)
Exact text from the filing
July 31, 2023, the Company was notified by the Staff that it had determined that the Company’s common stock had a closing bid price of $0.10 or less for ten consecutive trading days from July 17, 2023 through July 28, 2023. Accordingly, since the Company was subject to the provisions set forth under Listing Rule 5810(c)(3)(A)(iii), the Staff had determined to delist the Company’s securities from The Nasdaq Capital Market. The Company submitted a hearing request to Nasdaq’s Hearings Department, which stayed the suspension of the Company’s common stock pending the panel’s decision. The Company’s
View on SEC.gov
Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

EBET, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
stockholders equity
Rules
5550(b)(1)
Exact text from the filing
August 15, 2023, the Company received a letter from the Staff, which notified the Company that it does not presently comply with Nasdaq’s Listing Rule 5550(b)(1) (the “Listing Rule”), which requires that the Company maintain a minimum of $2.5 million in stockholders’ equity, and that the Company also does not meet the alternatives of market value of listed securities or net income from continuing operations set forth in the Listing Rule. The letter stated that, in addition to Bid Price Rule deficiency, the Nasdaq Hearings Panel will also consider the non-compliance with the Listing Rule in ren
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001683168-23-005931
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.